LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Erba Introduces XL Range of Fully Automated Clinical Chemistry Systems at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: Erba is attending Medlab Middle East 2023 (Photo courtesy of Erba Mannheim)
Image: Erba is attending Medlab Middle East 2023 (Photo courtesy of Erba Mannheim)

Erba Mannheim (London, UK) is introducing its latest XL range of fully automated clinical chemistry systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

At Medlab Middle East 2023, Erba is showcasing the XL range of four fully automated clinical chemistry systems that incorporate state-of-the-art features. These rugged and performance-oriented systems boost lab productivity and throughput, making them an essential part of any start-up, medium or advanced lab. They support a wide test menu spanning routine clinical chemistry, electrolytes, immunoassays and coagulation tests. The XL range includes the XL 1000 fully automated clinical chemistry analyzer that guarantees high resolution measurement with automatic sample conveyor for comfortable workflow in laboratories with high sample throughput. It also includes the XL 200 fully automated random access clinical chemistry analyzer having a throughput of 200 tests/hr (photometric test) and 400 tests/hr with ISE (Na/K/Cl/Li). Also part of the XL range is the XL 640 fully automated biochemistry analyzer with a throughput of 640 tests per hour that is powerful and robust enough to keep up with the heavy demands of everyday testing, as well as the XL 180 that is designed to give convenience and flexibility in operation and good quality reporting for small and medium-sized laboratories.

From its hematology line, Erba is highlighting the H360 automated 3-part differential hematology analyzer that can be used as a complete blood count analyzer by small laboratories or as a second instrument. Within its coagulation line, Erba is showcasing the ECL 105 single channel semi-automated system for small laboratories that performs measurements of all clotting assays as well as DDimer. With a color touch-screen and intuitive user interface, the ECL-105 is simple to use and ensures quality results. Also featuring at the show is the LAURA Smart urine strip reader which is an efficient and compact solution for routine chemical urinalysis. The equipment's semi-automatic technology facilitates the sample process, contributing to the correct diagnosis of patients. In addition, Erba is presenting the EC90 electrolyte analyzer featuring clean biosensor and maintenance-free technology. Designed for easy use, efficient operation and reliability, the EC90 has an analysis time of only 35 seconds.

Related Links:
Erba Mannheim 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Automatic ELISA Workstation
URANUS AE65

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics